A blood-biomarker based CTC-ALRI score predicts recurrence in hepatocellular carcinoma patients following curative resection.

Front Oncol · 2026 · PMC13033537 · PMID 41919246

Europe PMC DOI

hedged sentence

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

did not reach statistical significanceP = 0.062so close (0.05 < p ≤ 0.1)

In contrast, elevated ALRI (≥18) did not reach statistical significance for intrahepatic recurrence (Gray’s P = 0.062; Figure 7C ), but was significantly associated with a markedly higher cumulative incidence of extrahepatic recurrence (Gray’s P = 0.023; Figure 7D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.